Exane Derivatives’s Addus HomeCare ADUS Stock Holding History

Exane Derivatives’s Portfolio ADUS Stock Details ADUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,264	Closed	-$94.7K	–	655
2019 Q2	$94.7K	Buy	+1,264	New	+$87.3K	0.02%	337

Other funds holding ADUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EML

Eos Management LP New York $233M AUM 24.25% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return

Exane Derivatives's ADUS Position: Q3 2019 in Review

Exane Derivatives sold out of Addus HomeCare (ADUS) in Q3 2019, closing a stake of 1,264 shares — an estimated $94.7K sold.

Exane Derivatives first reported a position in ADUS in Q2 2019 and held it in 1 quarter. The position peaked at $94.7K in Q2 2019. 187 funds tracked by Wall St. Rank hold ADUS as of Q3 2019.

Exane Derivatives reported no remaining Addus HomeCare position as of Q3 2019 after selling out during the quarter.
Exane Derivatives sold 1,264 Addus HomeCare shares in Q3 2019, an estimated $94.7K.
Exane Derivatives first reported a position in Addus HomeCare in Q2 2019 and held it in 1 quarter.
Exane Derivatives's Addus HomeCare position peaked at $94.7K in Q2 2019.
187 funds tracked by Wall St. Rank held Addus HomeCare as of Q3 2019.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.